Rybelsus (semaglutide) is not recommended for use during pregnancy
Despite the success stories, some patients on Rybelsus and other GLP-1 drugs have reported severe side effects and health complications
For physiological pulsing simulations, the non-DAC variant in this blend is typically preferred
The article states that dual DPP-4 and GLP-1 therapy is generally safe with no major drug-drug interactions identified, and says the barrier is the modest efficacy gain rather than a safety problem
Wu XJ, Zhu JW, Jing J, Xue D, Liu H, et al
However, any patient reporting new symptoms of thyroid dysfunctionsuch as unexplained swelling at the base of the neck, sudden appetite changes, or severe fatigueshould contact their provider immediately for thyroid testing and evaluation